Cardioprotection during Adult and Pediatric Open Heart Surgery-Reference-Cited by-同舟云学术

Cardioprotection during Adult and Pediatric Open Heart Surgery

Published:2015 Issue: Volume:2015 Page:1-2
ISSN:2314-6133
Container-title:BioMed Research International
language:en
Short-container-title:BioMed Research International

Author:

Suleiman M-Saadeh¹,Underwood Malcolm²,Imura Hajime³^ORCID,Caputo Massimo⁴^ORCID

Affiliation:

1. Bristol Heart Institute, Level 7, Bristol Royal Infirmary, Faculty of Medicine & Dentistry, University of Bristol, Bristol, UK

2. Cardiothoracic Surgery, The Chinese University of Hong Kong, Faculty of Medicine, Prince of Wales Hospital, Shatin, Hong Kong

3. Cardiovascular Surgery, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8603, Japan

4. Congenital Heart Surgery, Royal Hospital for Children and University of Bristol, Level 7, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, UK

Publisher

Hindawi Limited

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://downloads.hindawi.com/journals/bmri/2015/712721.pdf

Reference4 articles.

1. Cardiopulmonary bypass-induced myocardial reoxygenation injury in pediatric patients with cyanosis

2. Controlled reoxygenation during cardiopulmonary bypass decreases markers of organ damage, inflammation, and oxidative stress in single-ventricle patients undergoing pediatric heart surgery

3. Propofol Is Cardioprotective in a Clinically Relevant Model of Normothermic Blood Cardioplegic Arrest and Cardiopulmonary Bypass

4. The Effects of Propofol Cardioplegia on Blood and Myocardial Biomarkers of Stress and Injury in Patients With Isolated Coronary Artery Bypass Grafting or Aortic Valve Replacement Using Cardiopulmonary Bypass: Protocol for a Single-Center Randomized Controlled Trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway;Frontiers in Pharmacology;2022-03-16